124 related articles for article (PubMed ID: 8697260)
1. New hope for treatment of Lou Gehrig's disease.
Piascik P
J Am Pharm Assoc (Wash); 1996 Jun; NS36(6):355-6. PubMed ID: 8697260
[No Abstract] [Full Text] [Related]
2. [Neurotrophic factor treatment in amyotrophic lateral sclerosis].
Tsuzaka K; Mitsumoto H
No To Shinkei; 1998 Jul; 50(7):625-30. PubMed ID: 9739520
[No Abstract] [Full Text] [Related]
3. The use of trophic factors in degenerative motoneuron diseases.
Yan Q; Miller JA
Exp Neurol; 1993 Nov; 124(1):60-3. PubMed ID: 8282082
[No Abstract] [Full Text] [Related]
4. Cephalon adds to clinical disappointment in 1997.
Glaser V
Nat Biotechnol; 1997 Jun; 15(6):495-6. PubMed ID: 9181559
[No Abstract] [Full Text] [Related]
5. USAN Council. List No. 419. New names. Mecasermin.
Clin Pharmacol Ther; 1999 Sep; 66(3):331. PubMed ID: 10576957
[No Abstract] [Full Text] [Related]
6. Cephalon's unusual NDA move.
Nat Biotechnol; 1998 Jan; 16(1):8. PubMed ID: 9447581
[No Abstract] [Full Text] [Related]
7. [Neurotrophic factors. Therapeutic approach in neurodegenerative diseases].
Wasielewski S
Med Monatsschr Pharm; 1992 Apr; 15(4):98-9. PubMed ID: 1584114
[No Abstract] [Full Text] [Related]
8. Neurotrophic factors and amyotrophic lateral sclerosis.
Askanas V
Adv Neurol; 1995; 68():241-4. PubMed ID: 8787236
[No Abstract] [Full Text] [Related]
9. Neuron saving schemes.
Lindsay RM
Nature; 1995 Jan; 373(6512):289-90. PubMed ID: 7830762
[No Abstract] [Full Text] [Related]
10. Life with Lou Gehrig's disease: managing ALS symptoms.
Valente SM; Karp JR
Nurse Pract; 2007 Dec; 32(12):26-33; quiz 33-4. PubMed ID: 18043408
[No Abstract] [Full Text] [Related]
11. Pathogenesis and therapy of amyotrophic lateral sclerosis. Introduction.
Serratrice GT; Munsat TL
Adv Neurol; 1995; 68():xix-xx. PubMed ID: 8787218
[No Abstract] [Full Text] [Related]
12. Amyotrophic lateral sclerosis. Helping the patient with Lou Gehrig's disease.
Bartels EJ
RN; 1979 Dec; 42(12):48-50, 79-82. PubMed ID: 261458
[No Abstract] [Full Text] [Related]
13. Use of growth factors in the treatment of motor neuron diseases.
Windebank AJ
Adv Neurol; 1995; 68():229-34. PubMed ID: 8787234
[No Abstract] [Full Text] [Related]
14. Can neurotrophic factors prevent or reverse motoneuron injury in amyotrophic lateral sclerosis?
Appel SH; Smith RG
Exp Neurol; 1993 Nov; 124(1):100-2. PubMed ID: 8282067
[No Abstract] [Full Text] [Related]
15. [Therapeutic potentials of neurotrophic factors for neurodegenerative disorders].
Okazawa H
No To Shinkei; 1996 Sep; 48(9):795-802. PubMed ID: 8888027
[No Abstract] [Full Text] [Related]
16. Neurotrophic factors in the treatment of motor neuron disease and trauma.
DiStefano PS
Exp Neurol; 1993 Nov; 124(1):56-9. PubMed ID: 8282081
[No Abstract] [Full Text] [Related]
17. Hopkins researchers close in on cause of Lou Gehrig's disease.
Compr Ther; 1992 Jun; 18(6):15. PubMed ID: 1511589
[No Abstract] [Full Text] [Related]
18. Will ciliary neurotrophic factor slow progression of motor neuron disease?
Longo FM
Ann Neurol; 1994 Aug; 36(2):125-7. PubMed ID: 8053646
[No Abstract] [Full Text] [Related]
19. Amyotrophic lateral sclerosis: current and future treatment strategies.
Festoff BW
Drugs; 1996 Jan; 51(1):28-44. PubMed ID: 8741231
[TBL] [Abstract][Full Text] [Related]
20. Amyotrophic lateral sclerosis: Lou Gehrig's disease.
Walling AD
Am Fam Physician; 1999 Mar; 59(6):1489-96. PubMed ID: 10193591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
